AFT loses challenge to ruling over ‘misleading’ Maxigesic ads
Alastair Vincent 2020-03-19 9:07 pm By Cat Fredenburgh | Melbourne
Please login to bookmark Close

AFT Pharmaceuticals has lost its challenge to a ruling that ads claiming its painkiller Maxigesic is more effective than Nuremol were misleading and deceptive, with the Full Federal Court saying the primary judge did not err in finding the ads lacked an adequate scientific basis.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au